🇺🇸 FDA
Patent

US 10987346

Iloperidone for the treatment of schizophrenia

granted A61KA61K31/454A61P

Quick answer

US patent 10987346 (Iloperidone for the treatment of schizophrenia) held by VANDA PHARMACEUTICALS INC. expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VANDA PHARMACEUTICALS INC.
Grant date
Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/454, A61P, A61P25/18